Serum GRP78 as a potential biomarker for early liver injury and active fibrogenesis in alcohol-associated liver disease. [PDF]
Liu Y +11 more
europepmc +1 more source
ABSTRACT Studies have shown that omega‐3 fatty acids may protect against cardiovascular diseases (CVDs) and related metabolic conditions. UK Biobank is a large cohort study that includes data on plasma omega‐3 fatty acids at study entry and health outcomes during the follow‐up period.
Warda Tul Firdous, Philip C. Calder
wiley +1 more source
Comment on: A cross-sectional analysis of liver disease-hypertension comorbid mortality trends in the United States, 1999-2023. [PDF]
Mayori F, Roy A.
europepmc +1 more source
Inflammatory gut-liver crosstalk: mechanisms and therapeutic targets. [PDF]
Murao A, Aziz M, Wang P.
europepmc +1 more source
What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol. [PDF]
Martyn E +14 more
europepmc +1 more source
Surveillance for viral hepatitis \u2014 United States, 2011
As part of CDC\u2019s National Notifiable Disease Surveillance System (NNDSS), viral hepatitis case-reports are received electronically from state health departments via CDC\u2019s National Electronic Telecommunications System for Surveillance (NETSS), a
core
Stigmatizing language in alcohol-associated cirrhosis open notes: Persistent but declining. [PDF]
Deng J +10 more
europepmc +1 more source
Accuracy of Surveys for Estimating Coverage for Hepatitis A and B Vaccinations in Adults. [PDF]
Crane LA +9 more
europepmc +1 more source
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley +1 more source
Menopausal hormone therapy and risk of liver cancer in a Swedish population-based cohort study. [PDF]
Huang Y +5 more
europepmc +1 more source

